Frederick P. Duncanson

1.2k total citations
18 papers, 918 citations indexed

About

Frederick P. Duncanson is a scholar working on Infectious Diseases, Epidemiology and Surgery. According to data from OpenAlex, Frederick P. Duncanson has authored 18 papers receiving a total of 918 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Infectious Diseases, 7 papers in Epidemiology and 3 papers in Surgery. Recurrent topics in Frederick P. Duncanson's work include Tuberculosis Research and Epidemiology (4 papers), Pneumonia and Respiratory Infections (3 papers) and Antifungal resistance and susceptibility (3 papers). Frederick P. Duncanson is often cited by papers focused on Tuberculosis Research and Epidemiology (4 papers), Pneumonia and Respiratory Infections (3 papers) and Antifungal resistance and susceptibility (3 papers). Frederick P. Duncanson collaborates with scholars based in United States, Japan and El Salvador. Frederick P. Duncanson's co-authors include Gary P. Wormser, Natalie C. Klein, Michael A. Pfaller, Mariana Castanheira, Ronald N. Jones, Carl W. Norden, Jiaxing Tan, Rodney M. Wishnow, David A. Talan and Martin Hirsch and has published in prestigious journals such as New England Journal of Medicine, CHEST Journal and The Journal of Infectious Diseases.

In The Last Decade

Frederick P. Duncanson

18 papers receiving 856 citations

Peers

Frederick P. Duncanson
Eddie Louie United States
Jeanine Bartlett United States
J.W. van ’t Wout Netherlands
Jennifer S. Daly United States
Arlo Upton New Zealand
John R. Black United States
Eddie Louie United States
Frederick P. Duncanson
Citations per year, relative to Frederick P. Duncanson Frederick P. Duncanson (= 1×) peers Eddie Louie

Countries citing papers authored by Frederick P. Duncanson

Since Specialization
Citations

This map shows the geographic impact of Frederick P. Duncanson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frederick P. Duncanson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frederick P. Duncanson more than expected).

Fields of papers citing papers by Frederick P. Duncanson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frederick P. Duncanson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frederick P. Duncanson. The network helps show where Frederick P. Duncanson may publish in the future.

Co-authorship network of co-authors of Frederick P. Duncanson

This figure shows the co-authorship network connecting the top 25 collaborators of Frederick P. Duncanson. A scholar is included among the top collaborators of Frederick P. Duncanson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Frederick P. Duncanson. Frederick P. Duncanson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Nielsen, Travis B., Paul Pantapalangkoor, Jun Yan, et al.. (2017). Diabetes Exacerbates Infection via Hyperinflammation by Signaling through TLR4 and RAGE. mBio. 8(4). 48 indexed citations
2.
Ahmed, Sarah, Wendy Kloezen, Frederick P. Duncanson, et al.. (2014). Madurella mycetomatis Is Highly Susceptible to Ravuconazole. PLoS neglected tropical diseases. 8(6). e2942–e2942. 35 indexed citations
3.
Wiederhold, Nathan P., Laura K. Najvar, Annette W. Fothergill, et al.. (2014). The Investigational Agent E1210 Is Effective in Treatment of Experimental Invasive Candidiasis Caused by Resistant Candida albicans. Antimicrobial Agents and Chemotherapy. 59(1). 690–692. 46 indexed citations
4.
Pfaller, Michael A., Frederick P. Duncanson, S. A. Messer, et al.. (2011). In Vitro Activity of a Novel Broad-Spectrum Antifungal, E1210, Tested against Aspergillus spp. Determined by CLSI and EUCAST Broth Microdilution Methods. Antimicrobial Agents and Chemotherapy. 55(11). 5155–5158. 64 indexed citations
5.
Castanheira, Mariana, Frederick P. Duncanson, Daniel J. Diekema, et al.. (2011). Activities of E1210 and Comparator Agents Tested by CLSI and EUCAST Broth Microdilution Methods against Fusarium and Scedosporium Species Identified Using Molecular Methods. Antimicrobial Agents and Chemotherapy. 56(1). 352–357. 79 indexed citations
6.
Krieter, Philip A., Mark Gohdes, Timothy J Musick, Frederick P. Duncanson, & William E. Bridson. (2007). Pharmacokinetics, Disposition, and Metabolism of Bicifadine in Humans. Drug Metabolism and Disposition. 36(2). 252–259. 17 indexed citations
7.
Duncanson, Frederick P., et al.. (2004). Declining Susceptibility to Neomycin and Polymyxin B of Pathogens Recovered in Otitis Externa Clinical Trials. Southern Medical Journal. 97(5). 465–471. 13 indexed citations
8.
Block, Stan L., et al.. (2004). Efficacy of ofloxacin otic solution once daily for 7 days in the treatment of otitis externa: A multicenter, open-label, phase III trial. Clinical Therapeutics. 26(7). 1046–1054. 13 indexed citations
9.
Flexner, Charles, William G. Powderly, Frederick P. Duncanson, et al.. (1994). Relationship Between Plasma Concentrations Of 3'-Deoxy-3'-Fluorothymidine (Alovudine) And Antiretroviral Activity In Two Concentration-Controlled Trials. The Journal of Infectious Diseases. 170(6). 1394–1403. 65 indexed citations
10.
Tan, Jiaxing, Rodney M. Wishnow, David A. Talan, Frederick P. Duncanson, & Carl W. Norden. (1993). Treatment of hospitalized patients with complicated skin and skin structure infections: double-blind, randomized, multicenter study of piperacillin-tazobactam versus ticarcillin-clavulanate. The Piperacillin/Tazobactam Skin and Skin Structure Study Group. Antimicrobial Agents and Chemotherapy. 37(8). 1580–1586. 81 indexed citations
11.
Klein, Natalie C., et al.. (1992). Trimethoprim-sulfamethoxazole versus pentamidine for Pneumocystis carinii pneumonia in AIDS patients. AIDS. 6(3). 301–306. 85 indexed citations
12.
Klein, Natalie C., et al.. (1989). Use of Mycobacterial Smears in the Diagnosis of Pulmonary Tuberculosis in AIDS/ARC Patients. CHEST Journal. 95(6). 1190–1192. 109 indexed citations
13.
Hewlett, Dial, et al.. (1988). Lymphadenopathy in an Inner-City Population Consisting Principally of Intravenous Drug Abusers with Suspected Acquired Immunodeficiency Syndrome. American Review of Respiratory Disease. 137(6). 1275–1279. 20 indexed citations
14.
Duncanson, Frederick P., Dial Hewlett, Shlomo Maayan, et al.. (1986). Mycobacterium tuberculosis infection in the acquired immunodeficiency syndrome. A review of 14 patients. Tubercle. 67(4). 295–302. 31 indexed citations
15.
Duncanson, Frederick P., et al.. (1985). Intestinal fistula formation in a man with mycobacterial disease and AIDS.. PubMed. 85(12). 702–4. 7 indexed citations
16.
Duncanson, Frederick P., et al.. (1985). Acquired Pelger-Huet Anomaly Associated with Mycoplasma pneumoniae Pneumonia. American Journal of Clinical Pathology. 84(2). 248–251. 7 indexed citations
17.
Hirsch, Martin, Gary P. Wormser, Robert T. Schooley, et al.. (1985). Risk of Nosocomial Infection with Human T-Cell Lymphotropic Virus III (HTLV-III). New England Journal of Medicine. 312(1). 1–4. 166 indexed citations
18.
Bottone, Edward J., Gary P. Wormser, & Frederick P. Duncanson. (1984). Nontyphoidal Salmonella bacteremia as an early infection in acquired immunodeficiency syndrome. Diagnostic Microbiology and Infectious Disease. 2(3). 247–250. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026